The Journal of Pharmacology and Experimental Therapeutics
Издатель: Elsevier · ISSN 0022-3565 · 45 статей
- IN VITRO AND IN VIVO ANTICANCER EVALUATION OF A QUERCETIN-DERIVED SCHIFF BASE IN A 4T1 BREAST CANCER MODEL
- Pharmacokinetic/Pharmacodynamic modeling of corticosteroids in a rat model for Cytokine Release Syndrome, Part III: Comparison of dexamethasone and methylprednisolone effects on cell trafficking and corticosterone responses
- Dihydroartemisinin ameliorates diabetic cardiomyopathy by inhibiting the CaN/NFAT3 signaling pathway
- Exploring the aryl hydrocarbon receptor/aldehyde oxidase relationship
- Resveratrol Attenuates Ferroptosis via the Nrf2/HO-1 Axis in Acute Carbon Monoxide Poisoning-Induced Myocardial Injury Based on target recognition: computational prediction of signal pathway regulation
- α-synuclein regulation of monoamine transporters: Implications for psychostimulant pharmacology and Parkinson disease
- Placenta-derived mesenchymal stem cells attenuate acute brain injury and neuroinflammation after intracerebral hemorrhage
- Interoceptive effects of N1-substituted lysergamides in rats: Role of agonist affinity at 5-hydroxytryptamine receptors and in vivo metabolism to lysergic acid diethylamide
- Strategic Substitutions of Agmatine Reduce Tactile Hypersensitivity in Peripheral Nerve Injury
- Intramuscular Administration of the Long-Acting Cocaine Hydrolase CocH5-Fc(M6) Protects Against Cocaine-Induced Toxicity in Male and Female Mice
- Propolis loaded nanogel: a targeted approach to mitigate CB1 /SIRT1/ HMGB1 signalling in gamma-radiation induced lung damage
- LIM Kinase Inhibitors Attenuate Prostate Enlargement and BOO-Associated Detrusor Pressure in Rat Models Relevant to Mixed LUTS.
- Advancing Exosome Research through Artificial Intelligence: Advancements and Applications
- Design and Functional Characterization of ERK1/2 Signaling Modulators in Lung Fibroblasts.
- Development of an experimental mouse model of immune checkpoint inhibitor-related myocarditis
- The Pharmacogenetics of Spironolactone in Neonates and Infants with Heart Disease
- Anxiolytic Effects of Cannabigerol: Hype or Hope?
- TFAP4 Promotes Glycolysis and Chemoresistance via Transcriptional Activation of PSAT1 in Colon Cancer
- Post-marketing safety signals of rabbit antithymocyte globulin in FAERS and JADER, 2004–2024
- Polydatin Attenuates 5-Fluorouracil-Induced Nephrotoxicity in Rats: Associated Changes in HMGB1/TLR4/MyD88, AMPK/mTOR and Endoplasmic Reticulum Stress-Related Markers
- From stress cytokine to drug target: The translational landscape of growth differentiation factor 15
- Pharmacokinetic and pharmacodynamic profile of high-dose D9-tetrahydrocannabinol in male and female rats
- Comparison of monosodium iodoacetate, medial meniscal transection, and partial medial meniscectomy in vivo rat models of osteoarthritis from the pain and industrial perspective
- Antinociceptive interaction of Δ9-tetrahydrocannabinol and cannabidiol in a humanized mouse model of sickle cell disease
- Locomotor stimulant and methamphetamine-like interoceptive effects of putative impurity N-ethyl-methamphetamine in rodents: Role of Phase I metabolism
- The phosphodiesterase 4B inhibitor A33 blocks locomotor stimulation by low doses of ethanol and diazepam
- Allosteric modulator of dopamine transporter inhibits cocaine-induced behaviors in rats
- C5aR2 signaling mechanisms via the β-arrestin–dependent pathway observed in microsecond-scale molecular dynamics simulations
- Leucine-rich repeat kinase 2 is involved in the microtubule-mediated regulation of intraocular pressure
- A self-assembling coculture model of retinal fibrosis reveals Bcl-xL inhibitors as cell-selective dual-mechanism antifibrotics